Close Menu

NEW YORK (GenomeWeb) – Curetis said today that its full-year 2018 revenues grew 17 percent year over year.

For the 12 months ended Dec. 31, 2018, the molecular diagnostics development firm reported revenues of €1.4 million ($1.6 million), up from €1.2 million in 2017.

The company said its R&D costs grew 43 percent year over year to €10.6 million from €7.4 million while its administrative costs were up 8 percent to €4.1 million from €3.8 million, and its distribution costs rose 12 percent to €8.2 million from €7.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.